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Copyright © 2008 JCBN Summary Using high sucrose-fed male Sprague-Dawley rats, a study was conducted to
determine the effects of feeding Galactomannan (GAL), a soluble dietary fiber extracted from
Canadian-grown fenugreek seeds, on blood lipid and glucose responses. Rats (n = 8, 175–200 g)
were randomly assigned to one of three high sucrose diets containing 10% cellulose (control),
7.5% cellulose + 2.5% GAL, and 5% cellulose + 5% GAL, respectively for 4 weeks. After 3
weeks, an oral glucose tolerance test (OGTT) was performed on each rat. A week later blood
samples were collected to determine the effect on blood lipids. A significant reduction in
glycemic response was observed only in 5% GAL group at 120 min following OGTT, when
compared with that of control and 2.5% GAL groups. The plasma level of insulin was also
significantly reduced (p<0.001) in 5% GAL-fed rats but at all times during OGTT. These
animals also showed a reduction in body weight gain (p<0.05) in parallel with less food intake
(p<0.05). All GAL-fed (2.5% and 5.0%) rats had significantly reduced plasma levels of
triglycerides and total cholesterol in association with a reduction in epididymal adipose weight.
Overall, this study demonstrated that feeding GAL from Canadian-grown fenugreek seeds has
the potential to alter glycemic and lipidemic status and reduce abdominal fat in normal rats.
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Introduction
Fenugreek (Trigonella foenum-graecum L.) is an annual
dicotyledon plant belonging to the family Papilionaceae
Leguminsae and is thought to originate in India and Middle
East. The seeds contain sapogenins, OH-isoleucine and
galactomannans, which have been shown to exert beneficial
health effects, specifically in diabetic and hypercholester-
olemic animals and humans [1]. Among the potential active
components of fenugreek seeds is galactomannan (GAL),
which is a guar gum representing approximately 50% of the
seed weight [2].
GAL extracted from fenugreek seeds of South Asian
origin has been shown to reduce postprandial blood glucose
[3] and improve insulin sensitivity in both non-diabetic [4,
5] and diabetic subjects [6–8]. The decrease in postprandial
blood glucose reduced the need for antidiabetic medication,
including insulin, in diabetic subjects consuming diets
containing guar gum. Feeding guar-GAL fibre has also been
shown to reduce both total and LDL cholesterol levels in
healthy and type 2 diabetic (T2D) subjects [9, 10]. However,
these results are not consistent among all studies. A guar
gum-containing diet, given for 4 weeks, failed to show anA. Srichamroen et al.
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improvement in glucose control in T2D subjects [11], while
a long-term ingestion of the fiber has been found to be
associated with increased plasma insulin concentrations
[12]. Further studies, involving healthy male subjects, also
reported no appreciable effects of the fiber in modifying
glycemic status [13]. It is possible that the discrepancies in
glycemic responses to GAL intake are caused by the differ-
ences in the fiber concentrations, type of foods, and duration
of the studies.
In recent years, fenugreek plant has been adapted to
cultivation in a Canadian province, Alberta. Unlike the
Asian variety of the plant, the potential health benefit of
GAL of this Canadian fenugreek has never been studied.
The present study was undertaken to examine the effects of
feeding GAL, isolated and purified from Canadian-grown
fenugreek seeds, in a high sucrose diet on blood lipids and
glycemic responses in normal Sprague-Dawley rats. The
high sucrose diet was chosen because of its established
effects on increasing triglycerides (TG) in both plasma and
adipose tissue [14].
Materials and Methods
Materials
GAL was extracted from fenugreek seeds (Amber variety)
in our laboratory. Briefly, seed coat fraction (0.5 mm mesh)
was dispersed in RO water, at a ratio of 1:40 (w/v) for 4 h.
After centrifugation at 17,700 × g for 30 min, the superna-
tant was mixed with absolute ethanol at a ratio of 1:1 (v/v) to
precipitate the fenugreek gum, which contained 91.4% (w/w)
GAL on a dry weight basis.
Animals and diets
Twenty-five male Sprague-Dawley rats (weighing 175–
200 g) were obtained from Charles River Laboratories
(Ontario, Canada). The animals were housed two per cage at
20–22°C and subjected to a 12-h day/night cycle. After a
week of acclimatization, animals were randomly divided
into three groups, which were fed a diet containing 0%
(control,  n = 9), 2.5% (low, n = 8), and 5% (high, n =8 )
GAL. Initial body weights of these animals were similar. All
rats had ad libitum access to water and food during the
experiment. The diets were high in sucrose (52% w/w),
isocaloric and isonitrogenous, and they contained 10% w/w
fibre, differed only in it’s composition as shown in Table 1.
All diets contained some cellulose, a non-fermentable and
non-soluble fiber, which was necessary to minimize the risk
of soluble fiber-associated diarrhea. The body weight and
the food intake were measured daily. The protocol of the
study was approved by the Faculty of Agriculture, Forestry
and Home Economics’ Animal Policy and Welfare
Committee (FAPWC), University of Alberta, Canada.
Oral glucose tolerance test
Animals were fed their respective diet for 3 weeks.
Following 12 h fast, each rat received an oral gavage of 75%
w/v glucose (3 g/kg BW). Blood samples were obtained
from tail at 0, 15, 30, 60, and 120 min after the glucose
challenge. Using the following calculation, the plasma and
insulin responses were determined as the area under the
curve (AUC) of plasma glucose and insulin:
AUC = 1/2(t2 − t1)(C2 +C 1) + 1/2(t3 − t2)(C3 +C 2)+
1/2(t4 − t3)(C4 +C 3) + 1/2(t5 − t4)(C5 +C 4),
Where C1, C2, C3, C4 and C5 are either plasma glucose or
plasma insulin at times 0 (t1), 15 (t2), 30 (t3), 60 (t4) and 120
min (t5), respectively, after glucose load.
Blood and tissue sampling
At the termination of the experiment (day 28), animals
were fasted for 12 h and anaesthetized with halothane.
Table 1. Composition of diets
The composition of diets was modified from AIN 93G. Polyunsaturated fatty acid to saturated fatty
acid (P/S) ratio was 0.4 based on approximate North American fat intake [31].
Control low GAL high GAL
Ingredients (g/100 g of diet):
Casein 20.0 20.0 20.0
Sucrose 52.0 52.0 52.0
Corn oil 5.0 5.0 5.0
Stearin 7.4 7.4 7.4
Linseed oil 0.5 0.5 0.5
DL-methionine 0.3 0.3 0.3
Choline bitartrate 0.2 0.2 0.2
Vitamin mix (AIN-93-VX) 1.1 1.1 1.1
Mineral mix (AIN-93-M) 3.5 3.5 3.5
Cellulose 10.0 7.5 5.0
Galactomannan 0.0 2.5 5.0Blood Glucose and Lipid Responses to Galactomannan
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Cardiac puncture was performed to obtain sufficient blood
for biochemical analyses. Tubes containing whole blood
were centrifuged at 3000 rpm for 15 min at 4°C (Beckman
J2-HC centrifuge, City, CA). The plasma samples were
stored at −80°C until analyzed. At necropsy, liver, epididymal
and peri-renal fat depots were excised, weighed, snap frozen
in liquid nitrogen and then stored at −80°C until analysed.
Biochemical analyses in plasma and tissue
Plasma glucose and insulin concentrations were deter-
mined by a glucose oxidase method (Biopacific Diagnostic
Inc., British Columbia, Canada) and a RIA kit [125I] (Linco
Research, City, MO), respectively. Plasma cholesterol and
triglyceride were determined using commercially available
enzymatic kits (Biopacific Diagnostic Inc.). Total free fatty
acids (FFA) in plasma were measured by using NEFA-C
Test Wako kit (Wako Pure Chemical Industries, City, VA).
Plasma lipoprotein fractions were separated by density
gradient ultracentrifugation (Optima MAX Ultracentrifuge,
Beckman coulter, City, CA) at 100,000 rpm for 3, 4, and 6 h
to obtain the fraction of VLDL, LDL, and HDL, respec-
tively, as described elsewhere (Wasan et al., 2001). The
different triglyceride and cholesterol molecules were
fractionated as follows: VLDL had a density (d) of 0.095–
1.006 kg/L, LDL had d = 1.006–1.063 kg/L, HDL had
d >1.063 kg/L [15]. Triglyceride and cholesterol concentra-
tions were determined for each of the fractions using
enzymatic kits (Biopacific Diagnostic Inc.).
Lipid from liver and adipose tissues was extracted by
chloroform/ methanol (2:1, v/v) solution as described by
Folch et al. [16]. Triglyceride and cholesterol concentrations
were measured using commercially available enzymatic kit
(Biopacific Diagnostic Inc.).
Adipose tissue histology
Difference in epididymal histology was determined by
analyzing two representative animals from each treatment
group. Frozen epididymal adipose tissues were thawed and
fixed in 10% (v/v) formalin. After 48 h of fixation, tissues
were dehydrated in graded alcohols, embedded in paraffin
blocks, and cut into sections of 5 µm thick. Mounted sections
were stained for light microscopy with haematoxylin and
eosin using standard methods [17]. The samples were
analyzed by an individual, who was blinded to the diet
treatment that the animals received.
Statistical analyses
Results were reported as the mean ± SEM. Statistical
analysis was performed by using one-way analysis of
variance (ANOVA), followed by Student-Newman-Keuls
(SNK) test as a post-hoc analysis to identify significant
differences among the groups. A p value<0.05 was consid-
ered statistical significance. Group means for body weight,
plasma glucose and plasma insulin, AUC were calculated
by repeated measurement analysis. The differences of AUC
between time points were determined using repeated
measurement analysis, and a SNK test was performed to
identify differences.
Results
Food intake, body and tissue weights
Food intake was significantly reduced by 16%, and 12%
for the high GAL group when compared with the control and
low GAL groups, respectively (p<0.05, Table 2). Body
weight of rats in all groups increased steadily with time, but
the average body weight of the animals fed a diet containing
high GAL diet was significantly lower on day 10 (by 6%)
and on day 28 (by 11%) compared to the control and the low
GAL groups (data not shown). Furthermore, the overall
body weight gain in the high GAL group was significantly
lower compared to the control and the low GAL groups
(p<0.05, Table 2). There were no differences in overall body
weight gain between the low GAL group and the controls.
The ratio of weight gain to gram of food intake in all 3
groups did not differ significantly (Table 2).
The low and high GAL groups had significantly less
epididymal adipose tissue than the control group by 23%
Table 2. Effect of galactomannan on food intake, weight gain, and adipose tissue weight
Values represent means ± SEM of control (n =9 ) ,  l o w  G A L  ( n = 8), high GAL (n =8 ) .
a–c values in a row not sharing a common superscript differ significantly at p<0.05.
Control low GAL high GAL
Food intake (g/d) 26.8 ± 0.8a 25.6 ± 0.8a 22.6 ± 0.8b
Body weight gain (g) 165.8 ± 9.7a 157.4 ± 10.3a 124.2 ± 10.3b
Body weight gain/ intake ratio 6.26 ± 0.1 6.10 ± 0.1 5.48 ± 0.1
Adipose tissue
epididymal adipose tissue (g) 5.90 ± 0.3a 4.57 ± 0.3b 2.58 ± 0.3c
% of body weight 1.5% 1.2% 0.7%
peri-renal adipose tissue (g) 1.38 ± 0.1 1.23 ± 0.1 0.91 ± 0.1
% of body weight 0.3% 0.3% 0.26%A. Srichamroen et al.
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and 56%, respectively (p<0.05, Table 2). However, there
were no significant differences in the weight of peri-renal
adipose tissue depot among these groups.
Oral glucose tolerance test
The average fasting plasma glucose concentration for the
high GAL group was reduced compared to the low GAL and
the control groups (p<0.05, results not shown). After the
OGTT, plasma glucose concentrations did not differ signifi-
cantly at 15, 30, and 60 min, while the glucose concentra-
tions in the high GAL group was significantly lower at
120 min as compared to the low GAL and the control groups
(p<0.05).
AUC between 0 and 120 min for glucose of high GAL
group was significantly reduced compared to the control and
low GAL groups (Table 3). Separate analysis of glucose
AUC between 30 and 60 min confirmed that the AUC for
the high GAL group was significantly lower than the
control. Between 60 to 120 min, the AUC of both low and
high GAL groups were significantly lower compared to the
control group. There were no differences in glucose AUC at
15 min (AUC 0 to 15 min), 30 min (AUC 15 to 30 min)
among all three groups.
Fasting plasma insulin in the high GAL group was lower
than that of the low GAL and the control groups (p<0.001,
Fig. 1). After the OGTT, plasma insulin of the high GAL
group was lower than the insulin levels of the low GAL and
control groups at 15, 30, 60 and 120 min (p<0.001). There
were no differences in plasma insulin concentrations
between the control and the low GAL groups.
Feeding both low and high GAL diets to rats resulted in
significantly lower AUC for insulin between 0 and 120 min
compared to the control (Table 4). The AUC for the high
GAL group was significantly lower than the control at all
measured time points. In low GAL group, compared to the
control group, there was a significantly lower AUC for
insulin at every measured time point, except at 30 min (AUC
15 to 30 min).
Triglyceride, free fatty acids and cholesterol concentrations
Both the low and high GAL groups had lower (p<0.05)
plasma triglyceride and cholesterol concentrations, com-
pared to the control (Fig. 2), while plasma FFA in the low
GAL group was significantly lower (Fig. 2). The plasma
FFA was found to be reduced only in the low GAL group.
VLDL triglyceride and cholesterol concentrations in plasma
did not differ significantly among diet treatments (Fig. 3 and
Table 3. Area under the curve of plasma glucose after OGTT
a–c Different letters following means ± SEM within a column indicate a significant difference at the 0.05 level.
Treatment 15 min 30 min 60 min 120 min
Total AUC 
(0 to120 min)
Control 144.5 ± 1.8 196.5 ± 1.8 386.7 ± 4.3a 633.8 ± 5.8a 1361.5 ± 12.5a
Low GAL 149.7 ± 1.8 199.3 ± 1.8 364.4 ± 4.3b 597.4 ± 5.8b 1310.9 ± 12.5a
High GAL 144.5 ± 1.8 191.3 ± 1.8 348.1 ± 4.3b 559.8 ± 5.8c 1239.9 ± 12.5b
Fig. 1. Plasma insulin response to the OGTT in rats fed one of
three diets for 3 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a-c Values in the same time point not sharing the same
superscript are significantly different (p<0.05).
Table 4. Area under the curve of plasma insulin after OGTT
a–c Different letters following means ± SEM within a column indicate a significant difference at the 0.05 level.
Treatment 15 min 30 min 60 min 120 min
Total AUC 
(0 to 120 min)
Control 1.45 ± 0.01a 1.87 ± 0.05a 3.49 ± 0.09a 5.2 ± 0.1a 12.1 ± 0.3a
Low GAL 1.28 ± 0.01b 1.81 ± 0.05a 3.04 ± 0.09b 3.9 ± 0.1b 10.1 ± 0.3b
High GAL 0.73 ± 0.01c 1.20 ± 0.05b 2.37 ± 0.09b 2.8 ± 0.1c 7.1 ± 0.3cBlood Glucose and Lipid Responses to Galactomannan
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4). High GAL group, however, had significantly lower LDL-
and HDL-TG concentrations than those of the control
animals. The low but not the high GAL group had signifi-
cantly lower concentrations of hepatic TG (p<0.05) than the
control (Fig. 5). Compared with the controls the hepatic
cholesterol concentration was, however, lower in both low
and high GAL groups.
Adipose fat
Epididymal triglyceride concentrations in the high GAL
group were reduced by 20% when compared to the control
group (p<0.05, Fig. 6). Upon histological examination the
epididymal adipose tissue of these animals was visibly
different from the control and low GAL-fed animals (Fig. 7).
The changes that were found to be present in the presence of
GAL included clusters of large fat cells surrounded by small
fat cells throughout adipose tissues, and capillaries that
appeared to be filled with erythrocytes.
Discussion
Fenugreek is a native of the Indian sub-continent and the
Eastern region. Its high adaptability to dry climate, high
yield and their ability to fix atmospheric nitrogen (N) make
it an ideal for short-term crop rotation in Northern countries,
such as Canada. An examination in our laboratory has
revealed that the Canadian-grown fenugreek seeds and the
seeds of a fenugreek variety, grown in India, are of similar
appearances, color, size, shape, odor, and anatomical
features. The chemical composition (e.g., crude lipids, 4-
hydroxyisoleucine, saponins) of Canadian fenugreek seeds
has also been found to be very similar to that of the seeds of
Indian origin. The Canadian variety, however, is significantly
higher in crude protein and GAL contents (unpublished data).
In rats, a high sucrose diet has been reported to result
Fig. 2. Plasma levels of total-triglyceride, total cholesterol, and
FFA in rats fed with different diets for 4 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a,b different superscripts indicate significant difference at
p<0.05 among control, low GAL and high GAL groups.
Fig. 3. Lipoprotein triglyceride levels in rats fed with different
diets for 4 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a,b different superscripts indicate significant difference at
p<0.05 among control, low GAL and high GAL groups.
Fig. 4. Lipoprotein cholesterol levels in rats fed with different
diets for 4 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a,b different superscripts indicate significant difference at
p<0.05 among control, low GAL and high GAL groups.
Fig. 5. Hepatic triglyceride and cholesterol levels in rats fed
with different diets for 4 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a,b different superscripts indicate significant difference at
p<0.05 among control, low GAL and high GAL groups.A. Srichamroen et al.
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hypertriglyceridemia, hyperglycemia, and hyperinsulinemia
[18, 19]. The diet is also known to impair insulin action,
leading to hypertriglyceridemia [20,  21]. In the present
study, an addition of 5% GAL to a high sucrose diet resulted
in a marked reduction in food intake in parallel with body
weight gain in rats, when fed for 4 weeks. GAL belongs to a
family of seed gum; it represents polymers of galactose and
mannose, and it is soluble in water [22]. Most soluble gum
fibers, such as guar gum, xanthan gum, gum acacia and
locust bean gum are viscous and that this property is thought
to delay gastric emptying and consequently intestinal
absorption [23]. However, the ratio of body weight gain to
food intake in all 3 groups in this study was similar. These
data indicated that the reduction in weight gain in the high
GAL group was likely due to reduced food intake, rather
than malabsorption. The fiber intake was also found to be
accompanied by a decreased rise in plasma insulin, which is
an important factor for appetite control [24]. It seems
probable that the reduced food intake in the presence of
GAL is caused by delaying in gastric empty (due to
viscosity) and promoting satiety (due to insulin inhibition)
of the soluble fiber. These results are in agreement with our
previous  in vitro study demonstrating reduced intestinal
glucose uptake with increasing GAL concentration in lean
and obese JCR rats [25]. This inhibition was found to be
associated with an increase in the viscosity of the GAL-
containing test solutions.
The present study was the first to demonstrate that feeding
a GAL diet for 4 weeks to normal rats, markedly reduces
the size of the abdominal adipose tissues compared with
the control counterpart, fed a similar diet but containing an
equivalent amount of cellulose as a fiber source. This result
can be explained by a decrease in insulin level leading to
reduced lipogenesis. The evidence of abdominal adipose
tissue histology from rats fed with 5% GAL containing diet
is suggestive of a high metabolic rate in the tissue, leading to
a release of FFA into the circulation.
One of the plausible mechanisms linking visceral adiposity
to insulin resistance is the liberation of non-esterified fatty
acids (NEFAs) from visceral depots to the liver. This NEFAs
in the liver, therefore, have a particularly important role in
bringing about many features of insulin resistance. Stimula-
tion of hepatic glucose synthesis may contribute to glucose
Fig. 6. Epididymal triglyceride level in rats fed with different
diets for 4 weeks.
Values represent means ± SEM of control (n = 9), low
GAL (n = 8), high GAL (n =8 ) .
a,b different superscripts indicate significant difference at
p<0.05 among control, low GAL and high GAL groups.
Fig. 7. Histology of epididymal adipose tissues from rats fed a
diet containing different levels of galactomannan for 4
weeks.
a) Rat fed with control diet b) Rat fed with low GAL
diet c) Rat fed with high GAL dietBlood Glucose and Lipid Responses to Galactomannan
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intolerance [26]. Stimulation of hepatic VLDL-TG secretion
may contribute to impaired postprandial lipid metabolism
(via competition with chylomicron-TG for peripheral
clearance) and the development of hypertriglyceridemia.
Given these facts, the high plasma and hepatic FFA in rats
fed a diet containing 5% GAL for 4 weeks, observed in the
present study, do not reflect insulin resistance. These rats
had lower plasma TG, while VLDL-TG levels remained
unchanged compared to the controls. The OGTT in these
animals also remained unaffected. These results indicate
that an underlying factor for the reduction of plasma insulin
level in GAL-fed rats may increase lipolysis in adipose
tissue, and consequently an increased plasma FFA levels and
a reduced adipocyte size. The GAL-associated decrease is
also accompanied by reductions in plasma and hepatic
concentrations of triglycerides, total cholesterol, and LDL-
cholesterol. These findings are in agreement with others,
which reported similar effects using other viscous fibers [27,
28]. The hypocholesterolemic effects of soluble fibers may
slow glucose absorption, because of their viscosity as well as
by binding bile acids in the intestinal lumen leading to a
decreased enterohepatic circulation [29]. Furthermore,
viscous fibers have been shown to increase the number of
LDL receptors in the liver of rats [30, 31]. An up-regulation
of the LDL receptors, therefore, increases clearance of LDL
cholesterol. The results of reduced hepatic cholesterol and
plasma LDL cholesterol in the present study, thus, suggest
the possibility of an increased clearance of cholesterol in the
liver.
In summary, GAL at 2.5% and 5% (w/w) reduced plasma
triglyceride, cholesterol and hepatic cholesterol concentra-
tions. GAL at 5% (w/w) resulted in lower food intake, which
may have enhanced the release of plasma FFA, and in turn,
led to the least amount (i.e. weight) of epididymal adipose
tissue. These results clearly demonstrate that GAL from
Canadian-grown fenugreek, a novel source of dietary fiber,
has the potential benefits in modifying both glycemic and
lipidemic status as well as body weight.
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